KR910002470A - 혈관 x선 촬영 보조제 - Google Patents

혈관 x선 촬영 보조제 Download PDF

Info

Publication number
KR910002470A
KR910002470A KR1019900010174A KR900010174A KR910002470A KR 910002470 A KR910002470 A KR 910002470A KR 1019900010174 A KR1019900010174 A KR 1019900010174A KR 900010174 A KR900010174 A KR 900010174A KR 910002470 A KR910002470 A KR 910002470A
Authority
KR
South Korea
Prior art keywords
angiography
ray
adjuvant
pge
activity
Prior art date
Application number
KR1019900010174A
Other languages
English (en)
Other versions
KR0160127B1 (ko
Inventor
야스유끼 고또오
Original Assignee
원본미기재
가부시끼가이샤 미도리 쥬우지
다이쇼 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 가부시끼가이샤 미도리 쥬우지, 다이쇼 세이야꾸 가부시끼가이샤 filed Critical 원본미기재
Publication of KR910002470A publication Critical patent/KR910002470A/ko
Application granted granted Critical
Publication of KR0160127B1 publication Critical patent/KR0160127B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음

Description

혈관 X선 촬영보조제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. PGE1활성을 가지는 화합물을 함유한 지방 에밀션을 함유하는 혈관 X선 촬영 보조제.
  2. PGE1활성을 가지는 화합물을 함유한 지방 에밀션을 인간에게 투여하고 대비 매체의 흐름을 관찰함을 특징으로 하는 인간의 혈관 X선 촬영 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900010174A 1989-07-05 1990-07-05 혈관 x선 촬영 보조제 KR0160127B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1-173709 1989-07-05
JP1173709A JPH0669966B2 (ja) 1989-07-05 1989-07-05 血管造影補助剤
JP01-173709 1989-07-05

Publications (2)

Publication Number Publication Date
KR910002470A true KR910002470A (ko) 1991-02-25
KR0160127B1 KR0160127B1 (ko) 1998-12-01

Family

ID=15965683

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900010174A KR0160127B1 (ko) 1989-07-05 1990-07-05 혈관 x선 촬영 보조제

Country Status (8)

Country Link
US (1) US5445812A (ko)
EP (1) EP0407148B1 (ko)
JP (1) JPH0669966B2 (ko)
KR (1) KR0160127B1 (ko)
CA (1) CA2020368C (ko)
DE (1) DE69021289T2 (ko)
DK (1) DK0407148T3 (ko)
ES (1) ES2076320T3 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135193C1 (ko) * 1991-10-22 1993-03-11 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De
US5807895A (en) * 1994-11-29 1998-09-15 Schwarz Pharma, Inc. Use of prostaglandin E1, E2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
WO1996016661A2 (en) * 1994-11-29 1996-06-06 Schwarz Pharma, Inc. Use of prostaglandin e1, e2 or analogs to prevent renal failure induced by medical tests that utilize contrast media agents
DE4446694A1 (de) * 1994-12-09 1996-06-13 Schering Ag Verwendung von Zusätzen zu Kontrastmitteln zur Verbesserung der Bildgebung
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6246897B1 (en) 1998-12-11 2001-06-12 General Electric Company Method and system for acquistion of preferential arterial and venous images for MR angiography
US6192264B1 (en) 1998-12-28 2001-02-20 General Electric Company Method and system for MRI venography including arterial and venous discrimination
US20080132797A1 (en) * 2002-12-10 2008-06-05 Knut Brabrand Monitoring infusion of a substance
AT518009A1 (de) * 2015-07-27 2017-06-15 Gebro Holding Gmbh Konzentrat enthaltend Alprostadil

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
JPS59206349A (ja) * 1983-05-10 1984-11-22 Green Cross Corp:The プロスタグランジンｅ↓１誘導体
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US5120527A (en) * 1989-10-19 1992-06-09 King Chuen Peter Li Paramagnetic oil emulsions as mri contrast agents
US5064636A (en) * 1989-10-19 1991-11-12 Li King C P Paramagnetic oil emulsions as enteric MRI contrast agents

Also Published As

Publication number Publication date
CA2020368A1 (en) 1991-01-06
DE69021289T2 (de) 1996-03-21
DE69021289D1 (de) 1995-09-07
EP0407148A2 (en) 1991-01-09
EP0407148A3 (en) 1992-01-08
CA2020368C (en) 2001-09-11
JPH0466540A (ja) 1992-03-02
DK0407148T3 (da) 1995-09-18
ES2076320T3 (es) 1995-11-01
EP0407148B1 (en) 1995-08-02
KR0160127B1 (ko) 1998-12-01
JPH0669966B2 (ja) 1994-09-07
US5445812A (en) 1995-08-29

Similar Documents

Publication Publication Date Title
KR910002470A (ko) 혈관 x선 촬영 보조제
ES2061055T3 (es) Vacunas y vectores de principios activos fluidos que contienen un aceite metabolizable.
KR830008660A (ko) 혈액겔화제를 함유한 생리대
KR920703071A (ko) 지질 저하제로서 콜레스티라민을 함유하는 미세정제
DE69016749D1 (de) Emulsion.
ES2058284T3 (es) Preparado capilar.
DE69020211D1 (de) Kosmetische Doppelemulsionszusammensetzung.
KR910004187A (ko) 세트랄린을 사용한 조기사정의 치료방법
SE8505047L (sv) Fettemulsion
GB1083683A (en) Diagnostic agents
DE69425552T2 (de) Emulsion auf der basis von 1-alpha,24-dihydroxy-vitamin d3
DE3585712D1 (de) Verwendung lang- und mittelkettiger triglyzeride.
ES2037742T3 (es) Procedimiento de obtencion de una composicion para administracion intravenosa.
PT100418A (pt) Emulsoes parentericas especificas contendo derivados lipofilicos iodados e/ou bromados e derivados do fenantreno como agente emulsionante e sua utilizacao comoagentes de contraste de raios x
Bowen et al. Diffuse vascular spasm associated with 4-bromo-2, 5-dimethoxyamphetamine ingestion
KR880013561A (ko) 발열 조성물
KR910000159A (ko) 코르티코 스테로이드 함유 연고제
KR890012659A (ko) 조산아의 뇌실내 출혈방지용 치료제
KR870005968A (ko) 아미드 유도체 및 이를 함유하는 외용약제
KR930019224A (ko) 유산 위험 치료제
KR870001823A (ko) 투명한 실리콘 조성물
KR870010082A (ko) 구아르(guar) 분말
SE7513814L (sv) Perfluorerade polycykliska foreningar anvendbara som blodersettnings- och perfusionsmedia
KR920702676A (ko) 신규 입체이성질체
KR910015294A (ko) 약제 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120626

Year of fee payment: 15

EXPY Expiration of term